Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes

OBJECTIVE: A number of clinical trials are underway to test whether mesenchymal stem cells (MSCs) are effective in treating various diseases, including type 1 diabetes. Although this cell therapy holds great promise, the optimal source of MSCs has yet to be determined with respect to major histocomp...

Descripción completa

Detalles Bibliográficos
Autores principales: Jurewicz, Mollie, Yang, Sunmi, Augello, Andrea, Godwin, Jonathan G., Moore, Robert F., Azzi, Jamil, Fiorina, Paolo, Atkinson, Mark, Sayegh, Mohamed H., Abdi, Reza
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Immunology and Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992776/
https://www.ncbi.nlm.nih.gov/pubmed/20841611
http://dx.doi.org/10.2337/db10-0542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992776/
https://www.ncbi.nlm.nih.gov/pubmed/20841611
http://dx.doi.org/10.2337/db10-0542

Ejemplares similares